- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-7771
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma ; volume:4 ; number:1 ; day:3 ; month:3 ; year:2016 ; pages:1-3 ; date:12.2016
Biomarker Research ; 4, Heft 1 (3.3.2016), 1-3, 12.2016
- Urheber
-
Narurkar, Roshni
- Beteiligte Personen und Organisationen
-
Alkayem, Mohammad
Liu, Delong
SpringerLink (Online service)
- DOI
-
10.1186/s40364-016-0060-9
- URN
-
urn:nbn:de:1111-2016031111662
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
08.08.20243024, 09:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Narurkar, Roshni
- Alkayem, Mohammad
- Liu, Delong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1
The drive to generate multiple forms of oncogenic cyclin D1 transcripts in mantle cell lymphoma
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
Clinical significance of Cyclin D1 by complete quantification detection in mantle cell lymphoma: positive indicator in prognosis
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
Smoldering mantle cell lymphoma
Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report
Mantle Cell Lymphoma Case Report
Relevance of cyclin D1b expression and CCND1polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
Mantle cell lymphoma with features of marginal-zone lymphoma
Emerging therapies in mantle cell lymphoma
Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1
The drive to generate multiple forms of oncogenic cyclin D1 transcripts in mantle cell lymphoma
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
Clinical significance of Cyclin D1 by complete quantification detection in mantle cell lymphoma: positive indicator in prognosis
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
Smoldering mantle cell lymphoma
Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report
Mantle Cell Lymphoma Case Report
Relevance of cyclin D1b expression and CCND1polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
Mantle cell lymphoma with features of marginal-zone lymphoma
Emerging therapies in mantle cell lymphoma
Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1
The drive to generate multiple forms of oncogenic cyclin D1 transcripts in mantle cell lymphoma
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
Clinical significance of Cyclin D1 by complete quantification detection in mantle cell lymphoma: positive indicator in prognosis
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
Smoldering mantle cell lymphoma
Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report
Mantle Cell Lymphoma Case Report
Relevance of cyclin D1b expression and CCND1polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
Mantle cell lymphoma with features of marginal-zone lymphoma